Antiretroviral Therapy does not Effect Pregnancy Outcomes

July 19, 2014 9:05 PM

49 0

In a new study, researchers examined fertility in couples made up of an HIV positive male and an HIV negative female who received antiretroviral pre-exposure preventive (PrEP) therapy. The team concluded that preventive therapy did not lead to any significant differences in pregnancy incidence, birth outcomes, and infant growth between women who got the treatment and women who received a placebo drug.

The researchers recruited 1,785 couples from Kenya and Uganda. 598 women received the daily PrEP oral treatment made with tenofovir disoproxil fumarate (TDF), 566 of them received a combination of TDF with emtricitabine/tenofovir disoproxil fumarate (FTC+TDF) and the remaining 621 received a placebo...

Read more

To category page